Evidence map›Paper›PMID 30097693›Full record

ReviewNeuroradiology2018

Neuroimaging of central diabetes insipidus-when, how and findings.

N C Adams, T P Farrell, A O'Shea, A O'Hare, J Thornton, S Power, P Brennan, S Looby

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neuroradiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Pituitary Stalk Lesion Sampling by Transsphenoidal Posterior Lobe Biopsy: A Case Series.Journal of neurological surgery. Part B, Skull base · 2026
    Article
  5. Arginine Vasopressin Deficiency and Oxytocin Deficiency in the Endocrine Clinic.The Journal of clinical endocrinology and metabolism · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Panhypopituitarism Mimicking Acute Coronary Syndrome.Internal medicine (Tokyo, Japan) · 2023
    Article
  11. Review
  12. Idiopathic partial central diabetes insipidus.Einstein (Sao Paulo, Brazil) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

N C AdamsDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland. adamsn@tcd.ie.ORCID http://orcid.org/0000-0001-7996-8812
T P FarrellDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland.
A O'SheaDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland.
A O'HareDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland.
J ThorntonDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland.
S PowerDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland.
P BrennanDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland.
S LoobyDepartment of Neuroradiology, Beaumont Hospital, Dublin 9, Ireland.
Beaumont Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central or neurogenic diabetes insipidus (CDI) is due to deficient synthesis or secretion of antidiuretic hormone (ADH), also known as arginine vasopressin peptide (AVP). It is clinically characterised by polydipsia and polyuria (urine output > 30 mL/kg/day) of dilute urine (< 250 mOsm/L). It is the result of a defect in one of more sites involving the hypothalamic osmoreceptors, supraoptic or paraventricular nuclei of the hypothalamus, median eminence of the hypothalamus, infundibulum or the posterior pituitary gland. A focused MRI pituitary gland or sella protocol is essential. There are several neuroimaging correlates and causes of CDI, illustrated in this review. The most common causes are benign or malignant neoplasms of the hypothalamic-pituitary axis (25%), surgery (20%), head trauma (16%) or familial causes (10%). No cause is identified in up to 30% of cases. Knowledge of the anatomy and physiology of the hypothalamo-neurohypophyseal axis is crucial when evaluating a patient with CDI. Establishing the aetiology of CDI with MRI in combination with clinical and biochemical assessment facilitates appropriate targeted treatment. The aim of the pictorial review is to illustrate the wide variety of causes of CDI on neuroimaging, highlight the optimal MRI protocol and to revise the detailed neuroanatomy and neurophysiology required to interpret these studies.

Indexed as

Diabetes Insipidus, NeurogenicHumansHypothalamo-Hypophyseal SystemMagnetic Resonance ImagingNeuroimagingCentral diabetes insipidusHypothalamic-neurohypophyseal axisHypothalamic pituitary axisMagnetic resonance imagingPosterior pituitary bright spot

Identifiers

PMID30097693
OpenAlexW2886791633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.